These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 26888408)
1. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408 [TBL] [Abstract][Full Text] [Related]
2. The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Brunt TM; Niesink RJ Drug Test Anal; 2011 Sep; 3(9):621-34. PubMed ID: 21898860 [TBL] [Abstract][Full Text] [Related]
3. Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Metcalfe C; Tindale K; Li H; Rodayan A; Yargeau V Environ Pollut; 2010 Oct; 158(10):3179-85. PubMed ID: 20667638 [TBL] [Abstract][Full Text] [Related]
4. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Giné CV; Espinosa IF; Vilamala MV Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121 [TBL] [Abstract][Full Text] [Related]
5. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Kalasinsky KS; Hugel J; Kish SJ J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119 [TBL] [Abstract][Full Text] [Related]
6. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329 [TBL] [Abstract][Full Text] [Related]
7. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands. van der Gouwe D; Brunt TM; van Laar M; van der Pol P Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283 [TBL] [Abstract][Full Text] [Related]
8. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS. Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502 [TBL] [Abstract][Full Text] [Related]
9. 4-Fluoroamphetamine in the Netherlands: more than a one-night stand. Linsen F; Koning RP; van Laar M; Niesink RJ; Koeter MW; Brunt TM Addiction; 2015 Jul; 110(7):1138-43. PubMed ID: 25808511 [TBL] [Abstract][Full Text] [Related]
10. The rise of new psychoactive substance use in Australia. Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890 [TBL] [Abstract][Full Text] [Related]
11. Is online information on ecstasy tablet content safe? Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128 [TBL] [Abstract][Full Text] [Related]
12. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration? Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144 [TBL] [Abstract][Full Text] [Related]
13. [High-risk drug use: epidemiological pattern through hair testing in the forensic context]. Burgueño MJ; Sánchez S; Castro MÁ; Mateos-Campos R Rev Esp Salud Publica; 2019 Nov; 93():. PubMed ID: 31767827 [TBL] [Abstract][Full Text] [Related]
14. Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004. Giraudon I; Bello PY Subst Use Misuse; 2007; 42(10):1567-78. PubMed ID: 17918027 [TBL] [Abstract][Full Text] [Related]
15. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands. Brunt TM; Niesink RJ; van den Brink W Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814 [TBL] [Abstract][Full Text] [Related]
16. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556 [TBL] [Abstract][Full Text] [Related]
17. Comparing illicit drug use in 19 European cities through sewage analysis. Thomas KV; Bijlsma L; Castiglioni S; Covaci A; Emke E; Grabic R; Hernández F; Karolak S; Kasprzyk-Hordern B; Lindberg RH; Lopez de Alda M; Meierjohann A; Ort C; Pico Y; Quintana JB; Reid M; Rieckermann J; Terzic S; van Nuijs AL; de Voogt P Sci Total Environ; 2012 Aug; 432():432-9. PubMed ID: 22836098 [TBL] [Abstract][Full Text] [Related]
18. Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology. Estévez-Danta A; Bijlsma L; Capela R; Cela R; Celma A; Hernández F; Lertxundi U; Matias J; Montes R; Orive G; Prieto A; Santos MM; Rodil R; Quintana JB Sci Total Environ; 2022 Aug; 836():155697. PubMed ID: 35523346 [TBL] [Abstract][Full Text] [Related]
19. mCPP: an undesired addition to the ecstasy market. Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863 [TBL] [Abstract][Full Text] [Related]
20. Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers. Kauert G; Röhrich J Int J Legal Med; 1996; 108(6):294-9. PubMed ID: 8793636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]